51
|
Rothschild C, Sabanai A, Santos A, Sousa C, Siqueira R, Ferretti T, Brandâo A, Diz M, Pereira J, Rocha V. PO-65 Pharmaceutical vigilance and education: the first 6 months of a new anticoagulant at a Brazilian cancer institute. Thromb Res 2021. [DOI: 10.1016/s0049-3848(21)00238-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
52
|
Ziza K, Gabe C, Conrado M, Oliveira V, Dezan M, Villaça P, Rocha V, Mendrone-Junior A, Dinardo C. PRESENÇA DE ANTICORPOS PLAQUETÁRIOS ANTI-CD41 E ANTI-CD61 CONTRA A GLICOPROTEÍNA IIB/IIIA EM PACIENTE COM TROMBASTENIA DE GLANZMANN. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
53
|
Silva W, Silverio A, Lino B, Aguiar T, Bendlin R, Massaut I, Pagnano K, Velloso E, Rocha V, Rego E. PHILADELPHIA-POSITIVE B-LYMPHOBLASTIC LEUKEMIA IN A DEVELOPING COUNTRY – TREATMENT-RELATED MORTALITY EXCEEDS RELAPSE IN ADULTS. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
54
|
Brandão A, Melo R, Bellesso M, Aranha M, Fernandes H, Farias D, Scheinberg P, Pereira J, Rego E, Rocha V. CLINICAL CHARACTERISTICS AND OUTCOMES OF BRAZILIAN PATIENTS WITH CASTLEMAN DISEASE: A BRAZILIAN MULTICENTRIC COHORT OF A RARE HEMATOLOGICAL DISORDER. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
55
|
Oliveira V, Conrado M, Dezan M, Rocha V, Mendrone-Junior A, Dinardo C. DIFFERENTIAL EXPRESSION OF TLR-2 AND CTLA-4 BETWEEN ALLOIMMUNIZED AND NON-ALLOIMMUNIZED INDIVIDUALS WITH SICKLE CELL DISEASE. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
56
|
Sinche M, Oliveira L, Machado P, Facincani T, Maio K, Nogueira F, Fonseca G, Rocha V, Nukui Y, Gualandro S. COMPARAÇÃO DO CONTROLE DE SOBRECARGA DE FERRO ENTRE REGIME DE TRANSFUSÃO DE TROCA MANUAL VERSUS ERITROCITAFÉRESE EM PACIENTES COM DOENÇA FALCIFORME. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
57
|
Nishiya A, Ferreira S, Salles N, Di-Lorenzo C, Rocha V, Mendrone-Jr A. ANÁLISE DA ACURÁCIA DE UM IMUNOENSAIO DE TRIAGEM SOROLÓGICA EM IDENTIFICAR OS DOADORES DE SANGUE VERDADEIROS POSITIVOS PARA O VÍRUS DA HEPATITE C (HCV). Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
58
|
Ziza K, Conrado M, Oliveira V, Dezan M, Gabe C, Villaça P, Rocha V, Mendrone-Junior A, Dinardo C. IDENTIFICAÇÃO DE ANTICORPOS PLAQUETÁRIOS PELO TESTE DE IMUNOFLUORESCÊNCIA PLAQUETÁRIA (PIFT) ASSOCIADO AO TESTE DE IMUNOENSAIO QUALITATIVO EM PACIENTES COM REFRATARIEDADE PLAQUETÁRIA. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
59
|
Azevedo R, Belli C, Perussini M, Ferri L, Pinheiro R, Magalhaes S, Traina F, Schuster S, Rocha V, Velloso E. AGE, PERFORMANCE STATUS AND LENALIDOMIDE THERAPY INDEPENDENTLY INFLUENCE THE OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) FROM SOUTH AMERICA. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
60
|
Cysne D, Okazaki E, Santos M, Rothschild C, Alencar R, Oliveira V, Rocha T, Rocha V, Villaça P. PLAQUETOPENIA INDUZIDA POR HEPARINA EM PACIENTE COM COVID-19: RELATO DE CASO. Hematol Transfus Cell Ther 2020. [PMCID: PMC7604220 DOI: 10.1016/j.htct.2020.10.925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
61
|
Oliveira L, Perruso L, Castelo L, Lage L, Seguro F, Pereira J, Nardinelli L, Bendit I, Rocha V. LEUCEMIA MIELOIDE CRÔNICA APRESENTANDO-SE COM RUPTURA ESPLÊNICA ESPONTÂNEA AO DIAGNÓSTICO: DESAFIOS EM ONCO-HEMATOLOGIA. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
62
|
Lima G, Perruso L, Barreto G, Castelo L, Cysne D, Aguiar R, Oliveira L, Mariano L, Martinez G, Rocha V. MIOPATIA NEMALÍNICA ESPORÁDICA DE INÍCIO TARDIO RELACIONADA À GAMOPATIA MONOCLONAL DE SIGNIFICADO INDETERMINADO: UM CASO RARO. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
63
|
Cysne D, Fonseca G, Gervatauskas K, Brandão A, Pereira J, Lage L, Bellesso M, Rocha V, Junior W. REATIVAÇÃO DO SARS COV 2 APÓS QUIMIOTERAPIA - RELATO DE CASO. Hematol Transfus Cell Ther 2020. [PMCID: PMC7604073 DOI: 10.1016/j.htct.2020.10.932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
64
|
Sharpley FA, Neffa P, Panitsas F, Eyre TA, Kothari J, Subesinghe M, Cutter D, Szor RS, Martinez GA, Rocha V, Ramasamy K. Correction: Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era. PLoS One 2019; 14:e0225184. [PMID: 31697780 PMCID: PMC6837372 DOI: 10.1371/journal.pone.0225184] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0219857.].
Collapse
|
65
|
Sharpley FA, Neffa P, Panitsas F, Kothari J, Subesinghe M, Cutter D, Shcolnik Szor R, Martinez GA, Rocha V, Ramasamy K. Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era. PLoS One 2019; 14:e0219857. [PMID: 31335866 PMCID: PMC6650037 DOI: 10.1371/journal.pone.0219857] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 07/02/2019] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND The risk of recurrence of solitary plasmacytoma (SP)/progression to MM is well established, but patient, imaging and treatment factors influencing risk of progression require further evaluation. METHODS This is a retrospective analysis of 66 SP patients (23 UK, 43 Brazil) diagnosed 1989-2016. Patient baseline characteristics were recorded. The incidence of progression to MM was calculated, including biochemical and imaging findings and the treatment modality received. Survival estimates were determined by Kaplan-Meier analyses. RESULTS With a median follow-up of 53.6 months the 5 year overall survival (OS) was 90.7% (95%CI 79-96%). The median progression free survival (PFS) from diagnosis was 61 months. Cumulative incidence of progression to MM was 49.9% at 5 years (95% CI 35.6-62.6%) and was significantly higher with bone plasmacytoma (47.2%, 95%CI 31.9-61.1%), than an extramedullary location (8.3%, 95%CI 0.4-32.3%, Gray test p = 0.0095)). The majority of patients with solitary bony plasmacytoma (SBP) received radiotherapy (RT) (51/53, 96.2%) whereas most extramedullary cases were treated with surgical resection (7/13, 53.8%). A small proportion of SBP patients received additional upfront chemotherapy, with 5/6 in remission after a median follow-up (FU) of 10 years. The diagnostic yield of surveillance functional FU imaging without other indications of relapse/progression was low. The positive predictive value of functional FU imaging was high but with a low negative predictive value, especially in cases of suspected relapse/progression. CONCLUSION Our data suggests functional imaging should be used if clinical suspicion of relapse/progression, rather than a routine surveillance tool, and upfront adjuvant chemotherapy is worthy of prospective evaluation.
Collapse
|
66
|
Balassa K, Griffiths A, Winstone D, Li Y, Rocha V, Pawson R. Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience. Transfus Med 2019; 29:332-337. [DOI: 10.1111/tme.12613] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Revised: 05/14/2019] [Accepted: 05/24/2019] [Indexed: 12/30/2022]
|
67
|
Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin J, Tischer J, Gülbas Z, Labussière Wallet H, Lopez Corral L, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, el Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, Gutiérrez García G, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A. HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP. Hematol Oncol 2019. [DOI: 10.1002/hon.108_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
68
|
Viana JD, Ferreira SC, Matana SR, Rossi F, Patel P, Garson JA, Rocha V, Tedder R, Mendrone-Júnior A, Levi JE. Detection of bacterial contamination in platelet concentrates from Brazilian donors by molecular amplification of the ribosomal 16S gene. Transfus Med 2018; 28:420-426. [PMID: 30304760 DOI: 10.1111/tme.12561] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2018] [Revised: 08/09/2018] [Accepted: 09/12/2018] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The aim of our work was to establish a semi-automated high-throughput DNA amplification method for the universal screening of bacteria in platelet concentrates (PCs). BACKGROUND Among cases of transfusion transmission of infectious agents, bacterial contamination ranks first in the number of events, morbidity and mortality. Transmission occurs mainly by transfused PCs. Automated culture is adopted by some blood banks for screening of bacterial contamination, but this procedure is expensive and has a relatively long turnaround time. METHODS PCs were spiked with suspensions of five different bacterial species in a final concentration of 1 and 10 colony-forming units (CFU) per millilitre. After incubation, the presence of bacteria was investigated by real-time polymerase chain reaction (PCR) and by the Enhanced Bacterial Detection System (eBDS, Pall) assay as a reference method. Real-time PCR amplification was performed with a set of universal primers and probes targeting the 16S rRNA gene. Co-amplification of human mitochondrial DNA served as an internal control. RESULTS Using the real-time PCR method, it was possible to detect the presence of all bacterial species tested with an initial concentration of 10 CFU mL-1 24 h after contamination, except for Staphylococcus hominis. The PCR assay also detected, at 24 h, the presence of Serratia marcescens and Enterobacter cloacae with an initial concentration of 1 CFU mL-1 . CONCLUSIONS The real-time PCR assay may be a reliable alternative to conventional culture methods in the screening of bacterial contamination of PCs, enabling bacterial detection even with a low initial concentration of microorganisms.
Collapse
|
69
|
Rocha V, Ribeiro A, Soares S, Stringhini S, Fraga S. Socioeconomic circumstances and respiratory function in childhood and adolescence: A systematic review and meta-analysis. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
70
|
Ferreira AM, Moreira F, Guimaraes T, Spadão F, Ramos JF, Batista MV, Filho JS, Costa SF, Rocha V. Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization. J Hosp Infect 2018. [PMID: 29530743 DOI: 10.1016/j.jhin.2018.03.004] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND Bloodstream infections (BSI) are a major complication in the early phase of a haematopoietic stem cell transplant (HSCT). AIM To describe the incidence and risk factors for BSI occurring in the pre-engraftment phase of HSCT, and its impact on mortality. METHODS Clinical variables of 232 HSCT patients were analysed retrospectively between 2014 and 2015. Univariate Cox regression analyses were performed to test the association between each covariate and the outcome. Covariates with P < 0.10 on univariate analysis were included in a multiple Cox regression analysis using a backward elimination method. FINDINGS The cumulative incidence of BSI was 25.4%, mainly caused by Gram-negative bacteria (GNB) (55.2%). Approximately 40.5% of the patients had gut colonization by multi-drug-resistant (MDR) bacteria (vancomycin-resistant enterococcus and carbapenem-resistant GNB). Among patients colonized by MDR GNB, 20% developed an overt BSI due to MDR bacteria with the same pattern of sensitivity. Of the 13 deaths related to infection, 10 were patients with BSI caused by MDR GNB. The independent risk factors for BSI were gut colonization by MDR bacteria including GNB (P < 0.001) and duration of neutropenia >10 days (P = 0.005), and those associated with BSI caused by MDR bacteria were age >62 years (P = 0.03), use of total parenteral nutrition (TPN) (P < 0.001) and previous gut colonization by MDR GNB (P = 0.002). CONCLUSIONS Previous gut colonization by MDR was an independent risk factor for BSI, together with TPN and age, and had an impact on outcome. These findings suggest that gut decolonization may be a potential strategy to prevent BSI.
Collapse
|
71
|
Soares S, Rocha V, Fraga S. Childhood violence, inflammation and DNA methylation: a systematic review. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
72
|
Oliveira VB, Dezan MR, Gomes FCA, Menosi Gualandro SF, Krieger JE, Pereira AC, Marsiglia JD, Levi JE, Rocha V, Mendrone-Junior A, Sabino EC, Dinardo CL. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients. Int J Immunogenet 2017; 44:219-224. [PMID: 28815969 DOI: 10.1111/iji.12334] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 05/23/2017] [Accepted: 07/20/2017] [Indexed: 02/06/2023]
Abstract
Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) molecule is expressed on T-lymphocyte membrane and negatively influences the antigen-presenting process. Reduced expression of CTLA-4 due to gene polymorphisms is associated with increased risk of autoimmune disorders, whose physiopathology is similar to that of post-transfusion red blood cell (RBC) alloimmunization. Our goal was to evaluate if polymorphisms of CTLA-4 gene that affect protein expression are associated with RBC alloimmunization. This was a case-control study in which 134 sickle cell disease (SCD) patients and 253 non-SCD patients were included. All patients were genotyped for the polymorphisms 49A/G and -318C/T of CTLA-4 gene. The genotype frequency of -318C/T differed significantly between alloimmunized and nonalloimmunized SCD patients, irrespective of clinical confounders (p = .016). SCD patients heterozygous for -318T allele presented higher risk of alloantibody development (OR: 5.4, CI: 1.15-25.6). In conclusion, the polymorphism -318C/T of CTLA-4 gene is associated with RBC alloimmunization among SCD patients. This highlights the role played by CTLA-4 on post-transfusion alloantibody development.
Collapse
|
73
|
Dinardo C, Kerbauy M, Santos T, Lima W, Dezan M, Oliveira V, Mendrone-Júnior A, Rocha V, Velloso E. Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population. Int J Lab Hematol 2017; 39:e144-e146. [DOI: 10.1111/ijlh.12712] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2017] [Accepted: 06/16/2017] [Indexed: 11/27/2022]
|
74
|
Salgado M, Kwon M, Gálvez C, Nijhuis M, Wiesch JS, Bandera A, Knops E, Badiola J, Jensen B, Saez-Cirión A, Jurado M, Kaiser R, Hutter G, Rocha V, Kobbe G, Wensing A, Diez J, Martinez-Picado J. OA5-1 Achievement of full donor chimerism with episodes of alloreactivity contributes to reduce the HIV reservoir after allogeneic stem cell transplantation. J Virus Erad 2017. [DOI: 10.1016/s2055-6640(20)30843-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
75
|
Nguyen S, Achour A, Souchet L, Vigouroux S, Chevallier P, Furst S, Sirvent A, Bay JO, Socié G, Ceballos P, Huynh A, Cornillon J, Francois S, Legrand F, Yakoub-Agha I, Michel G, Maillard N, Margueritte G, Maury S, Uzunov M, Bulabois CE, Michallet M, Clement L, Dauriac C, Bilger K, Lejeune J, Béziat V, Rocha V, Rio B, Chevret S, Vieillard V. Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord. Bone Marrow Transplant 2017. [PMID: 28650455 DOI: 10.1038/bmt.2017.122] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Unrelated cord blood transplantation (UCBT) after a reduced intensity conditioning regimen (RIC) has extended the use of UCB in elderly patients and those with co-morbidities without an HLA-identical donor, although post-transplant relapse remains a concern in high-risk acute myeloid leukemia (AML) patients. HLA incompatibilities between donor and recipient might enhance the alloreactivity of natural killer (NK) cells after allogeneic hematopoietic stem-cell transplantation (HSCT). We studied the reconstitution of NK cells and KIR-L mismatch in 54 patients who underwent a RIC-UCBT for AML in CR in a prospective phase II clinical trial. After RIC-UCBT, NK cells displayed phenotypic features of both activation and immaturity. Restoration of their polyfunctional capacities depended on the timing of their acquisition of phenotypic markers of maturity. The incidence of treatment-related mortality (TRM) was correlated with low CD16 expression (P=0.043) and high HLA-DR expression (P=0.0008), whereas overall survival was associated with increased frequency of NK-cell degranulation (P=0.001). These features reflect a general impairment of the NK licensing process in HLA-mismatched HSCT and may aid the development of future strategies for selecting optimal UCB units and enhancing immune recovery.
Collapse
|